Scientists Find How High Blood Sugar Helps Cancer Cells Hide From the Immune System

Scientists have identified a mechanism that may explain how some tumors evade the immune system: a thick, sugar-rich coating that cancer cells build around themselves, which grows even more effective at high blood sugar levels.

The coating, called the glycocalyx, is a dense outer layer of sugar-derived molecules that naturally surrounds most cells in the body. Researchers at Sanford Burnham Prebys Medical Discovery Institute, working with collaborators across North America, found that cancer cells can exploit this layer as a disguise - thickening it enough to physically block T cells, antibodies, and other immune defenders from reaching receptors on the tumor's surface.

The study, published August 7 in Science Advances, found that high blood sugar strengthens this shield under conditions that mimic the environment inside a tumor. A protein called HSF1 appears to play a central role in that thickening process, responding to the surrounding tumor microenvironment - the mix of immune cells, connective tissue, blood vessels, and other molecules around a tumor - to reinforce the cancer cell's camouflage.

The finding adds a biological explanation to something oncologists have suspected for years: that poorly controlled blood sugar tends to correlate with worse cancer outcomes. If elevated glucose is directly helping tumors hide from the immune system, that would be a more concrete mechanism than the general metabolic explanations that have dominated the conversation so far.

There's also a potential treatment angle. In lab experiments, inhibiting HSF1 prevented the sugary shield from thickening, effectively stripping away the tumor's disguise and letting immune cells recognize and attack it. That opens the door to drugs designed to target HSF1 specifically - potentially making existing immunotherapies more effective by making tumors easier to spot in the first place, rather than needing to boost the immune system's attack power directly.